CME Symposium- Anticoagulant Reversal in Stroke: Best Practices for Successful Outcomes

This CME Symposium takes place during the 2023 International Stroke Conference #ISC23 on Wednesday, February 8, 2023 from 6:30 PM CT - 8:30 PM CT at the Omni Dallas Hotel, 555 S. Lamar Street, Dallas, Texas.

DALLAS - Dec. 27, 2022 - PRLog -- In this CME Symposium, during the 2023 International Stroke Conference (#ISC23), expert faculty will discuss the importance of anticoagulant reversal therapies and situations that warrant the administration of such therapies. Stroke specialists must be able to identify appropriate candidates for anticoagulant reversal in persons suffering an ischemic or hemorrhagic stroke, as well as how to select the most appropriate reversal therapy on an individualized patient basis. In particular, clinicians must have a greater recognition of the risks and potential consequences of anticoagulant reversal in patients receiving anticoagulant therapies and the treatment algorithms for initiating reversal therapy in the diverse and expanding patient populations who use anticoagulants. The growing reliance on non-vitamin K direct oral anticoagulants (DOACs) instead of traditional oral vitamin K anticoagulants (VKAs) necessitates knowledge regarding DOAC-specific reversal agents, including their benefits, risks, timing, dosing, and appropriate indications in order to optimize outcomes.

Click here for more information

CHAIR:
Truman J. Milling, Jr., MD
Associate Professor of Neurology
Associate Professor of Surgery and Perioperative Care
Dell Medical School
The University of Texas at Austin
Austin, Texas

FACULTY:
Joshua N. Goldstein, MD, PhD
Professor of Emergency Medicine
Harvard Medical School
Boston, Massachusetts

William F. Peacock, MD
Professor of Medicine-Emergency Medicine
Baylor College of Medicine
Houston, Texas

Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

This educational activity is intended for #neurology, #emergencymedicine, #criticalcare, #cardiology and other clinicians managing patients experiencing a #stroke.

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Pre-registration is for planning purposes only and does not guarantee seating. For additional CME activities visit CMEPlanet. #ISC23 #cardiology #stroke #anticoagulation #DOAC #VKA #neurology #EM

Contact
Voxmedia
***@voxmedia.us
Photos: (Click photo to enlarge)



Read Full Story - CME Symposium- Anticoagulant Reversal in Stroke: Best Practices for Successful Outcomes | More news from this source

Press release distribution by PRLog